Daniel Watterson

4.6k total citations · 1 hit paper
86 papers, 2.1k citations indexed

About

Daniel Watterson is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Daniel Watterson has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 45 papers in Public Health, Environmental and Occupational Health and 21 papers in Epidemiology. Recurrent topics in Daniel Watterson's work include Mosquito-borne diseases and control (44 papers), Viral Infections and Vectors (36 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Daniel Watterson is often cited by papers focused on Mosquito-borne diseases and control (44 papers), Viral Infections and Vectors (36 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Daniel Watterson collaborates with scholars based in Australia, United Kingdom and United States. Daniel Watterson's co-authors include Paul R. Young, Naphak Modhiran, Katryn J. Stacey, David A. Muller, Keith J. Chappell, David Hume, Lidong Liu, David P. Sester, Jody Hobson‐Peters and Roy A. Hall and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Daniel Watterson

83 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity

2015 406 citations Naphak Modhiran, Daniel Watterson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Watterson Australia	27	1.3k	1.2k	356	319	318	86	2.1k
James Weger‐Lucarelli United States	27	1.6k 1.3×	1.8k 1.5×	354 1.0×	537 1.7×	258 0.8×	79	2.4k
Huot Khun France	20	1.2k 0.9×	1.3k 1.1×	271 0.8×	207 0.6×	300 0.9×	27	2.4k
Sukathida Ubol Thailand	28	1.6k 1.3×	1.8k 1.5×	443 1.2×	131 0.4×	463 1.5×	75	2.8k
Rosa María del Ángel Mexico	34	1.8k 1.4×	2.1k 1.7×	317 0.9×	411 1.3×	857 2.7×	108	3.3k
Chunya Puttikhunt Thailand	24	1.9k 1.6×	2.3k 1.9×	274 0.8×	317 1.0×	309 1.0×	59	2.8k
Beate M. Kümmerer Germany	32	1.8k 1.4×	1.5k 1.2×	405 1.1×	237 0.7×	670 2.1×	64	3.2k
Shingo Inoue Japan	28	1.8k 1.4×	1.4k 1.1×	366 1.0×	160 0.5×	639 2.0×	143	3.3k
Kevin R. Porter United States	38	2.8k 2.3×	3.0k 2.4×	422 1.2×	222 0.7×	515 1.6×	90	4.2k
Kent Barbian United States	23	1.9k 1.5×	1.5k 1.2×	596 1.7×	145 0.5×	803 2.5×	42	3.1k
Eric Martínez France	24	2.0k 1.6×	2.9k 2.4×	214 0.6×	320 1.0×	378 1.2×	51	3.6k

Countries citing papers authored by Daniel Watterson

Since Specialization

Citations

This map shows the geographic impact of Daniel Watterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Watterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Watterson more than expected).

Fields of papers citing papers by Daniel Watterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Watterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Watterson. The network helps show where Daniel Watterson may publish in the future.

Co-authorship network of co-authors of Daniel Watterson

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Watterson. A scholar is included among the top collaborators of Daniel Watterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Watterson. Daniel Watterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bibby, Summa, James Jung, Alberto A. Amarilla, et al.. (2025). A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity. Nature Communications. 16(1). 8449–8449.

Parry, Rhys, Wendy R. Hood, Yang Zhao, et al.. (2025). Henipavirus in Northern Short-Tailed Shrew, Alabama, USA. Emerging infectious diseases. 31(2). 392–394.

Nahain, Abdullah Al, Jinlin Li, Naphak Modhiran, et al.. (2024). Antiviral Activities of Heparan Sulfate Mimetic RAFT Polymers Against Mosquito-borne Viruses. ACS Applied Bio Materials. 7(5). 2862–2871. 2 indexed citations

Harrison, Jessica J., Bing Tang, Gervais Habarugira, et al.. (2024). A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge. npj Vaccines. 9(1). 134–134. 10 indexed citations

Vajjhala, Parimala R., Sara J Thygesen, Daniel Watterson, et al.. (2023). Kinetics of severe dengue virus infection and development of gut pathology in mice. Journal of Virology. 97(11). e0125123–e0125123. 6 indexed citations

Amarilla, Alberto A., John D. Lee, Eduardo A. Albornoz, et al.. (2022). SARS‐CoV ‐2 triggers complement activation through interactions with heparan sulfate. Clinical & Translational Immunology. 11(8). e1413–e1413. 13 indexed citations

Slonchak, Andrii, Xiaohui Wang, Julio Aguado, et al.. (2022). Zika virus noncoding RNA cooperates with the viral protein NS5 to inhibit STAT1 phosphorylation and facilitate viral pathogenesis. Science Advances. 8(48). eadd8095–eadd8095. 29 indexed citations

Shalash, Ahmed O., Armira Azuar, Naphak Modhiran, et al.. (2022). Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems. Pharmaceutics. 14(4). 856–856. 8 indexed citations

Shalgunov, Vladimir, Umberto Maria Battisti, David Schwefel, et al.. (2022). Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein. PubMed. 2. 1033697–1033697. 1 indexed citations

10.

McMillan, Christopher L. D., Paul R. Young, Daniel Watterson, & Keith J. Chappell. (2021). The Next Generation of Influenza Vaccines: Towards a Universal Solution. Vaccines. 9(1). 26–26. 21 indexed citations

11.

Shalash, Ahmed O., Armira Azuar, Naphak Modhiran, et al.. (2021). Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay. Vaccines. 9(12). 1493–1493. 8 indexed citations

12.

Isaacs, Ariel, Stacey T. M. Cheung, Nazia Thakur, et al.. (2021). Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates. Viruses. 13(10). 1942–1942. 10 indexed citations

13.

McMillan, Christopher L. D., Adi Idris, Aroon Supramaniam, et al.. (2021). Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine. Science Advances. 7(44). eabj8065–eabj8065. 32 indexed citations

14.

O’Brien, Caitlin A., Cassandra L. Pegg, Amanda Nouwens, et al.. (2020). A Unique Relative of Rotifer Birnavirus Isolated from Australian Mosquitoes. Viruses. 12(9). 1056–1056. 8 indexed citations

15.

Thakur, Nazia, Carina Conceicao, Ariel Isaacs, et al.. (2020). Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion. Journal of General Virology. 102(1). 12 indexed citations

16.

Pedrera, Miriam, Francesca Macchi, Rebecca McLean, et al.. (2020). Bovine Herpesvirus-4-Vectored Delivery of Nipah Virus Glycoproteins Enhances T Cell Immunogenicity in Pigs. Vaccines. 8(1). 115–115. 29 indexed citations

17.

Modhiran, Naphak, Neha S. Gandhi, Norbert Wimmer, et al.. (2019). Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545. Antiviral Research. 168. 121–127. 29 indexed citations

18.

Asad, Sultan, Mazhar Hussain, Leon E. Hugo, et al.. (2018). Suppression of the pelo protein by Wolbachia and its effect on dengue virus in Aedes aegypti. PLoS neglected tropical diseases. 12(4). e0006405–e0006405. 26 indexed citations

19.

Colmant, Agathe M. G., Jody Hobson‐Peters, Helle Bielefeldt‐Ohmann, et al.. (2017). A new clade of insect-specific flaviviruses from Australian Anopheles mosquitoes displays species-specific host restriction. Eukaryotic Cell. 5 indexed citations

20.

Faddy, Helen M., Natalie A. Prow, Daniel Watterson, et al.. (2016). Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light. Transfusion. 56(6pt2). 1548–1555. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact